PTRF-Cavin, a Conserved Cytoplasmic Protein Required for Caveola Formation and Function  by Hill, Michelle M. et al.
PTRF-Cavin, a Conserved
Cytoplasmic Protein Required for
Caveola Formation and Function
Michelle M. Hill,1,2 Michele Bastiani,1,2,6 Robert Luetterforst,1,2,6 Matthew Kirkham,1,2,6,3 Annika Kirkham,1,2,6,4
Susan J. Nixon,1,2 Piers Walser,1,2 Daniel Abankwa,1 Viola M.J. Oorschot,1,2,5 Sally Martin,1,2 John F. Hancock,1
and Robert G. Parton1,2,*
1Institute for Molecular Bioscience
2Centre for Microscopy and Microanalysis
University of Queensland, Brisbane, Queensland 4072, Australia
3Present address: Department of Cell and Molecular Biology, Karolinska Institute, 17177 Stockholm, Sweden.
4Present address: Biovitrum AB, SE-112 76 Stockholm, Sweden.
5Present address: Cell Microscopy Center, Department of Cell Biology, University Medical Center Utrecht, The Netherlands.
6These authors contributed equally to this work.
*Correspondence: r.parton@imb.uq.edu.au
DOI 10.1016/j.cell.2007.11.042SUMMARY
Caveolae are abundant cell-surface organelles in-
volved in lipid regulation and endocytosis. We used
comparative proteomics to identify PTRF (also called
Cav-p60, Cavin) as a putative caveolar coat protein.
PTRF-Cavin selectively associates with mature cav-
eolae at the plasma membrane but not Golgi-local-
ized caveolin. In prostate cancer PC3 cells, and
during development of zebrafish notochord, lack of
PTRF-Cavin expression correlates with lack of
caveolae, and caveolin resides on flat plasma mem-
brane. Expression of PTRF-Cavin in PC3 cells is suf-
ficient to cause formation of caveolae. Knockdown of
PTRF-Cavin reduces caveolae density, both in mam-
malian cells and in the zebrafish. Caveolin remains on
the plasma membrane in PTRF-Cavin knockdown
cells but exhibits increased lateral mobility and
accelerated lysosomal degradation. We conclude
that PTRF-Cavin is required for caveola formation
and sequestration of mobile caveolin into immobile
caveolae.
INTRODUCTION
Caveolae are a characteristic and abundant morphological fea-
ture of many mammalian cells. Caveolae have been implicated
in numerous functions including cell signaling, lipid regulation,
and endocytosis. The only known structural proteins of caveolae
are members of the caveolin family, caveolin-1 (Cav1), caveolin-
2 (Cav2), and caveolin-3 (Cav3). Cav1 is expressed in nonstriated
muscle cells and drives caveolae formation. Caveolae are absent
from nonmuscle tissues of Cav1/ animals (Drab et al., 2001)
and ectopic expression of Cav1 in cells lacking caveolae leadsto de novo caveolae formation (Fra et al., 1995). Cav3 is ex-
pressed in skeletal and cardiac muscle (Pol et al., 2005; Way
and Parton, 1995) and is required for caveolae formation in these
cells (Galbiati et al., 2001; Hagiwara et al., 2000). In contrast,
Cav2 is not required for caveolae formation (Razani et al.,
2002), and its transport to the plasma membrane is dependent
on Cav1 expression (Parolini et al., 1999). Cav1 binds cholesterol
(Murata et al., 1995) and forms higher-order oligomers (Monier
et al., 1996). These properties are believed to be important for
generation of the characteristic structure of caveolae, each of
which contains approximately 144caveolinmolecules (Pelkmans
and Zerial, 2005). Caveolae may be generated in the Golgi com-
plex, as a unit that fuses directly with the plasma membrane (Ta-
gawaet al., 2005).While the role of caveolin in caveolae formation
is therefore well established (Parton et al., 2006), it is not known
whether other proteins are required for caveolae formation or if
they can regulate the balance between caveolae formation and
disassembly.
Caveolae play an important role in the regulation of many cel-
lular functions. For example, downregulation of Cav1 has been
correlated with cell transformation and tumor invasion (Williams
and Lisanti, 2005). Precisely how caveolae/caveolins regulates
cellular processes remains unclear. In contrast to the dynamic
transient nature of many signal transduction complexes, caveo-
lae are generally extremely stable structures (Tagawa et al.,
2005; Thomsen et al., 2002). The caveolar unit stays intact de-
spite cycles of endocytosis, fusion with the caveosome or endo-
somes, and recycling back to the plasma membrane (Pelkmans
and Zerial, 2005). However, caveolin becomesmobile upon cho-
lesterol depletion and a large-scale screen identified kinases that
when downregulated cause significant changes in caveolin dis-
tribution (Pelkmans et al., 2005). This suggests that the formation
of the caveolar unit may be regulated.
To gain further insights into caveolar function we utilized
comparative proteomics of Cav1/ and wild-type (WT) mouse
embryonic fibroblasts and found Polymerase I and transcriptCell 132, 113–124, January 11, 2008 ª2008 Elsevier Inc. 113
release factor, PTRF, to be targeted to detergent-resistant mem-
branes (DRM) in a Cav1-dependent manner. PTRF, also called
Cav-p60 or Cavin, was previously localized to caveolae by the
group of Tranum-Jensen using antibodies derived from rat
adipocyte membranes (Vinten et al., 2001, 2005; Voldstedlund
et al., 2001, 2003). More recently, PTRF was identified as a com-
Figure 1. Identification of PTRF as a Protein
Enriched in Cav1-Containing DRM
(A and B) DRM prepared from WT and Cav1/ MEF
were analyzed by (A) SDS-PAGE (5%–15%) and col-
loidal Coomassie staining or (B) 2D gel electrophoresis
(pH 3–10, 12%) and silver staining.
(C) Slices from a 12% colloidal Coomassie-stained
SDS-PAGE gel were digested with trypsin and ana-
lyzed by mass spectrometry. PTRF and SDPR were
identified in WT but not Cav1/ DRM. TIS (total ion
score) and %C.I (% confidence interval) from Mascot
searches are shown.
(D) The enrichment of PTRF inWTDRMwas confirmed
by western blotting and compared with selected sig-
naling proteins.
(E) Expression of PTRF, caveolin, and flotilllin-1 was
examined by western blotting in MEF, and adult tissue
lysates prepared fromWT and Cav1/mice. Twenty
micrograms of each lysate was loaded, and the mem-
brane was Coomassie stained to confirm protein load-
ing. The blots are representative of two independent
tissue lysates. SDS-PAGE molecular weight markers
are shown in kDa. Adr, adrenal gland; Sk. Mus, skele-
tal muscle.
ponent of immunopurified caveolae from
human adipocytes (Aboulaich et al., 2004).
PTRF is a soluble protein with putative leu-
cine zipper, nuclear localization sequences,
and PEST domains (Aboulaich et al., 2004;
Gustincich et al., 1999). We now show that
PTRF-Cavin is required for formation of cav-
eolae in cultured cells and zebrafish embryo.
RESULTS
Analysis ofDRM fromWTandCav1/
MEFs Reveal Minor Differences in
Presence/Absence of Caveolin
In order to identify putative caveolae pro-
teins,we employed a comparative proteomic
screen using detergent-resistant mem-
branes (DRM) prepared from WT and
Cav1/ murine embryonic fibroblasts
(MEFs). While DRM do not equate to caveo-
lae or lipid raft domains (Lichtenberg et al.,
2005), this strategy represents a nonbiased
approach to identify proteins recruited to
this fraction, directly or indirectly, by caveo-
lin. Since Cav1/ cells are devoid of mor-
phological caveolae, proteins that are absent
in Cav1/ DRM compared to WT DRM are
expected to be components of caveolae. As
shown in Figure 1, the protein profile for WT and Cav1/ DRM
are extremely similar, both on SDS-PAGE (Figure 1A) and on
2DE (Figure 1B), consistent with the fact that caveolae proteins
represent only a minor proportion of the total DRM proteins.
To identify proteins specific to WT DRM, gel slices were
excised from entire lanes of Coomassie-stained SDS-PAGE,114 Cell 132, 113–124, January 11, 2008 ª2008 Elsevier Inc.
digested with trypsin, and analyzed by MS/MS. After two inde-
pendent TOF-TOF analyses, 53 common proteins were identi-
fied in WT and Cav1/ DRM, while 8 proteins were found to
be preferentially enriched in WT DRM and 6 proteins enriched
inCav1/ DRM. PTRF was identified as a protein preferentially
enriched in WT DRM (Figure 1C). In addition, a related protein,
serum-deprivation response protein (SDPR) was also found
enriched in WT DRM (Figure 1C).
Consistent with the proteomic data, western blotting showed
that a PTRF immunoreactive band of 60 kDa was significantly
reduced in Cav1/ DRM (Figure 1D). This difference was con-
sistently observed in numerous DRM preparations, while the
abundance of many other signaling proteins were found to be
similar between WT and Cav1/ DRM, including eNOS, Src,
PKB, and Fyn (Figure 1D). Indeed, the only signaling protein
we found to target to DRM in a Cav1-dependent manner was
protein kinase Ca (PKCa, Figure 1D). To examine whether the re-
duction of PTRF in Cav1/ DRM is a result of an overall reduc-
tion in PTRF protein, we performed immunoblotting for PTRF in
MEF whole cell lysates, as well as lysates of adult mouse tissues
(Figure 1E). The expression of PTRF was similar in WT and
Cav1/MEF whole cell lysates (Figure 1E). In adult mouse tis-
sues, PTRF showed an expression pattern that strictly correlated
with caveolin, with highest expression in lung, fat, and adrenal
gland, and intermediate expression in heart and skeletal muscle
(Figure 1E). A second PTRF-immunoreactive band at 25 kDawas
detected inmouse tissues but not inMEFs (Figure 1E). The inten-
sity of this band paralleled that of full-length PTRF in most tis-
sues, suggesting that it may be a degradation product, possibly
corresponding to the reported cleaved PTRF (Aboulaich et al.,
2004). Intriguingly, PTRF expression is dramatically reduced in
Cav1/ adult mouse tissues (Figure 1E), strongly suggesting
that these two proteins are functionally linked.
PTRF Associates with Caveolae
PTRF was recently identified as a component of immunopurified
caveolae from human adipocytes (Aboulaich et al., 2004), and as
cav-p60, a protein previously localized to rat adipocyte caveolae
(Vinten et al., 2005). To confirm the subcellular localization of
PTRF in fibroblasts, we performed immunofluorescence (IF) con-
focal microscopy in WT MEF and NIH 3T3 cells. In addition to
a cytosolic pool, PTRF showed punctate cell surface staining,
which colocalized with Cav1-enriched regions of the plasma
membrane (Figures 2A and 2B). Detailed analysis of the confocal
images revealed that all plasma membrane Cav1 puncta were
colabeled with PTRF, whereas a small number of Cav1-free
PTRF puncta could also be detected. To confirm that PTRF is
localizing to caveolae, we performed immunoelectron micros-
copy (immuno-EM) on plasma membrane lawns (Prior et al.,
2003) generated from baby hamster kidney (BHK) cells cotrans-
fected with Cav1-mGFP and PTRF-RFP. Cav1 and PTRF were
detected by GFP and RFP antibodies coupled to 6 nm and
2 nm gold, respectively. As shown in Figure 2C, Cav1 and
PTRF both labeled caveolae, although low levels of expressed
PTRF were also detected on flat membrane.
By IF,Cav1/MEF showed a diffuse distribution of either en-
dogenous or ectopically expressed PTRF (Figures 2D and 2E),
consistent with limited plasmamembrane association or bindingto flat membrane. To determine whether the alteration of PTRF
subcellular localization in Cav1/, MEF was a direct result of
loss of Cav1, Cav1 was re-expressed in Cav1/ MEF. Immu-
noblotting showed that expression of Cav1 caused recruitment
of PTRF to the DRM fraction (Figure 3A), and IF analysis showed
recruitment of PTRF to caveolin-enriched puncta at the plasma
membrane (Figure 3B). These results show that Cav1 is neces-
sary and sufficient to recruit PTRF to the plasma membrane.
In addition to the cell surface, caveolins are also present in the
Golgi complex in many cells, corresponding to a pool of newly
synthesized protein (Nichols, 2002; Pol et al., 2005). As Cav1
recruits PTRF to the plasma membrane we investigated whether
PTRF is also recruited to the Golgi complex. Endogenous PTRF
colocalized with Cav1 at the plasma membrane but not at the
Golgi complex in WT MEF (Figure 2A) and NIH 3T3 fibroblasts
(Figure 2B). Expression of Cav1 or Cav3 in Cav1/ MEFs is
Figure 2. PTRF Associates with Caveolae
(A and B) WT MEF (A) and NIH 3T3 (B) fibroblasts grown on coverslips were
labeled for endogenous Cav1 and PTRF, then examined by confocal micros-
copy. In both cell types Cav1 and PTRF show extensive colocalization in cell
surface puncta. Bars, 10 mm.
(C) Immuno-EM of plasma membrane sheet shows colabeling of Cav1-GFP
(6 nm gold) with PTRF-RFP (2 nm gold; arrowheads) in cotransfected BHK
cells. Bar, 100 nm.
(D and E) Cav1/MEF labeled for endogenous PTRF, or (E) transfected with
PTRF-Flag and labeled for the Flag tag show diffuse labeling of PTRF. Live cell
images of GFP-PTRF in unfixed WT and KO MEF are available in Figure S1.Cell 132, 113–124, January 11, 2008 ª2008 Elsevier Inc. 115
sufficient to generate caveolae (Kirkham et al., 2005). Expression
of Cav1 (Figure 3B) or Cav3 (Figure 3C) in Cav1/ MEFs also
caused the recruitment of PTRF to the plasma membrane, but
not the Golgi complex (arrowheads in Figure 3C). To further char-
acterize this apparent selectivity for caveolin at the plasmamem-
brane, we examined a series of caveolin mutants with different
Figure 3. Cav1 Expression Is Sufficient to Recruit PTRF to DRM;
PTRF Is Recruited to the Cell Surface by Caveolae-Generating
Forms of Cav1 and Cav3 But Is Not Recruited to Caveolin at the Golgi
Complex
(A) DRMs prepared fromWTMEF,Cav1/MEF, and Cav1/MEF in which
Cav1 was re-expressed by infection with adenovirus Cav1, was analyzed by
western blotting for PTRF, Flotillin-1, and Cav1.
(B–H) Cav1/ MEF cotransfected with PTRF-Flag and Cav1-HA (B),
Cav3-HA (C), Cav3 P104L-HA (D), Cav3 C71W-JA (E), C. elegans caveolin
(Ce-Cav1-Cherry, panel F), Apis mellifera caveolin (Bee-Cav-HA, panel G) or
zebrafish-Cav1-YFP (H) were fixed, labeled with anti-Flag antibody and anti-
HA antibody where required. The localization of expressed PTRF and caveolin
was examined by confocal microscopy. Note that C. elegans Cav1 (Ce-Cav1-
Cherry) associates with the cell surface but does not generate caveolae (data
not shown) and does not recruit PTRF to the plasma membrane. Bars, 10 mm.116 Cell 132, 113–124, January 11, 2008 ª2008 Elsevier Inc.subcellular localizations. Golgi-associated mutants of Cav3,
such asCav3P104L, were unable to recruit PTRF (Figure 3D). An-
othermutant, Cav3C71W,which localizes both to the cell surface
(to generate caveolae, data not shown), and the Golgi complex
shows recruitment of PTRF to the cell surface but not to theGolgi
complex (Figure 3E, arrowhead).
To further clarify the requirement of caveola formation in PTRF
recruitment, we assessed the ability of caveolins from different
species—ranging from mammals to invertebrates—to recruit
PTRF. In agreement with the results from caveolin mutants, there
was a strict correlation between caveolae formation and PTRF
recruitment (Figures 3F–3H). Caveolin from C. elegans, which
is also surface localized but is unable to generate caveolae,
did not recruit PTRF to the plasmamembrane (Figure 3F). In con-
trast, zebrafish caveolin generated caveolae and recruited PTRF
to the plasma membrane (Figure 3H). Remarkably, an inverte-
brate caveolin from the honey bee A. mellifera, which generated
caveolae, caused PTRF recruitment (Figure 3G). Hybrid proteins
between mammalian and CeCav also showed the same correla-
tion between caveolae formation and PTRF recruitment
(Figure S2), further strengthening the conclusion that only
plasma membrane caveolar caveolin recruits PTRF.
PTRF and Caveolin Are in Close Proximity
at the Plasma Membrane
The above results prompted us to examine the possible interac-
tion between PTRF and caveolin. We employed the in situ tech-
niques of sensitized acceptor emission and fluorescence lifetime
imaging (FLIM) and fluorescence resonance energy transfer
(FRET) to examine whether PTRF and caveolin are in close prox-
imity. For FRET studies, monomeric fluorescent proteins were
used to tag PTRF and Cav1, and then cotransfected into BHK
cells. FRET was detected in vesicular structures, which lined
the plasma membrane and were also distributed in the cell pe-
riphery (Figures 4A and S3). All structures where mCFP-PTRF
and Cav1-mCit colocalized displayed FRET with an efficiency
of 10%–20%. For FLIM studies, mGFP-PTRF was transfected
into BHK cells or cotransfected withmRFP-Cav3, and its fluores-
cence lifetime measured. The fluorescence lifetime of mGFP-
PTRF was significantly reduced (p < 0.0001) when mRFP-Cav3
was coexpressed (Figure 4B). We further estimate that approxi-
mately 20% of PTRF molecules are sufficiently proximate to an
mRFP-Cav3 acceptor molecule to undergo FRET (Figure 4B).
Taken together, these results show that PTRF and caveolin are
closely associated at the plasma membrane.
To gain additional insights into themechanismof PTRF recruit-
ment to caveolae, we estimated the stoichiometry of PTRF re-
cruitment to DRM by caveolin. mGFP-PTRF and Cav3-mGFP
were cotransfected in Cav1/ MEF at a ratio of 3:1, so that all
cells expressing mGFP-PTRF should express Cav3-mGFP.
DRMs were prepared and examined by immunoblotting with
anti-GFP antibody. As expected, cotransfection of Cav3-mGFP
with mGFP-PTRF caused a recruitment of mGFP-PTRF to the
DRM (Figure S4). In control dishes where GFP was used in place
of Cav3-mGFP, only a trace amount of mGFP-PTRF was de-
tected in the DRM (Figure S4). Quantitative immunoblotting esti-
mated the ratio of Cav3-mGFP to mGFP-PTRF in the DRM to be
5.5 ± 1.9 (range between 2.1 and 8.6, n = 3). The high variation of
Figure 4. PTRF and Caveolin Interacts in
a Cholesterol-Dependent Manner; PTRF Is
Required for Caveola Formation in PC3
Cells
(A) BHK cells were transiently transfected with
mCFP-PTRF and mCit-Cav1. The distribution of
mCFP-PTRF is observed in the donor channel
and mCit-Cav1 in the acceptor channel image.
FRET was observed in vesicular structures along
the plasma membrane (arrowheads) and at the
cell periphery (arrows). FRET was calculated per
pixel as a sensitized acceptor emission index FR,
ranging from 1 (no FRET) to 10. Overlay of a binary
colocalization image (green pixels) and a binary
FRET image showing all pixels with FR > 2 in black
revealed that all structures where mCFP-PTRF
and mCit-caveolin-1 colocalized also exhibited
FRET. Bars, 2 mm.
(B) BHK cells transiently expressing mGFP-PTRF
with or without mRFP-Cav3 were imaged in
a wide-field FLIM microscope. Representative
FLIM images are shown and the fluorescence life-
time (ns) of mGFP displayed as a heat map. In the
presence of the acceptor mRFP the lifetime of the
donor mGFP is significantly decreased; this was
quantified by calculating the mean lifetime of
mGFP on a cell-by-cell basis (mean ± SEM, n R
50 cells from three independent experiments).
The reduced mGFP lifetime reflects FRET be-
tween mGFP and mRFP as a result of the molecu-
lar proximity of PTRF and Cav3. The fraction of
donor fluorophores undergoing FRET was ex-
tracted from the FLIM data (see Experimental Pro-
cedures). *p < 0.0001.
(C) FLIM experiment was performed as described
for (B), except that cells were treated with 1%
Methyl-b-cyclodextrin for 20 min (MCD) or left un-
treated (CON). Data represent mean fluorescence
lifetime ± SEM. *p < 0.001.
(D) PTRF binding to phosphatidylserine (PS) in
a solid-phase assay. Each spot contained 2 mg
of phospholipid with gradual decrease of the an-
ionic phospholipid content as indicated. Binding
of PTRF was detected by immunoblotting. PG,
phosphatidylglycerol; DOPC, dioleoylphosphati-
dylcholine.
(E) PTRF binding to acidic phospholipids was as-
sayed by cosedimentation with liposomes con-
taining decreasing amounts of phosphatidylserine
(PS, mass balanced by phosphatidylcholine, PC).
U, unbound fraction; B, bound fraction. Binding
of PTRF is essentially absent in liposomes lacking
PS.
(F) The protein levels of PTRF and Cav1 was examined by immunoblotting in 10 mg of total cell lysates from HeLa and PC3 cells. Tubulin was used as a loading
control.
(G) PC3 cells grown on glass coverslips were transfected with PTRF-cherry, and labeled for endogenous Cav1. The example image shows one transfected cell
(left) and one untransfected cell (right) in the same field.
(H) Control or PTRF-transfected PC3 cells were fixed in the presence of ruthenium red to label the cell surface and examined by electron microscopy. Control
cells show few uncoated invaginations with the morphology of caveolae; note the 120 nm coated vesicle (arrowhead). In transfected cells, numerous uncoated
pits (arrowheads) with the typical morphology of single caveolae and caveolae rosettes are evident. Caveolae density increased from 0.26 ± 0.13 caveolae per
field in control cells to 1.70 ± 0.94 in PTRF transfected cells. Transfection efficiency was approximately 50%. Bars, 200 nm.estimates obtained with this method may be due to dissociation
of PTRF during preparation of DRM and prompted us to perform
an independent, fluorescence-based assay to refine the esti-
mates of the PTRF:caveolin stoichiometry. NIH 3T3 cells trans-fected with either Cav3-mGFP or PTRF-mGFP were imaged by
confocal microscopy using the same capture conditions in
each case. Mean gray level values were measured for particles
that fitted within a 0.177 mm2 circle, with the assumptions thatCell 132, 113–124, January 11, 2008 ª2008 Elsevier Inc. 117
each puncta correspond to one caveola and that contribution of
endogenous caveolin/PTRF in caveolae is negligible upon high
overexpression. The mean gray level value for Cav3 and PTRF
was 22.28 ± 0.46 (n = 127) and 23.45 ± 0.62 (n = 100), suggesting
that caveolin and PTRF are present in an approximate 1:1 ratio
within caveolae.
Coimmunoprecipitation of PTRF with Cav1, with and without
in vivo crosslinking, using either PTRF, caveolin, GFP, or Flag an-
tibodies under different solubilization conditions provided equiv-
ocal results (data not shown). This raises the possibility that
PTRF associates with the specific lipid environment generated
by caveolin. Cav1 binds cholesterol (Murata et al., 1995), and de-
pletion of cellular cholesterol results in a loss of morphological
caveolae (Hailstones et al., 1998). To determine if PTRF-caveolin
interaction requires cholesterol, we used methyl-b-cyclodextrin
to extract cholesterol and then examined the interaction by
FLIM. Cholesterol depletion to 50% attenuates PTRF-caveolin
interaction as measured by an increase in the fluorescence life-
time of mGFP-PTRF (Figure 4C), correlating with the reported
loss of morphological caveolae under these conditions (Hail-
stones et al., 1998). PTRF shares sequence homology with
SDPR and SRBC (serum deprivation response-related gene
product that binds to c-kinase), both of which have been shown
to bindphosphatidylserine (PS) (Burgener et al., 1990;Gustincich
et al., 1999; Izumi et al., 1997), and caveolin peptides have been
reported to generate PS-rich domains in vitro (Wanaski et al.,
2003). We therefore examined if PTRF could bind PS in vitro.
Recombinant PTRF bound pure PS in a solid-phase assay, with
the interaction completely lost when phosphatidylcholine (PC)
was included at a 50-fold excess (Figure 4D). This interaction
was further confirmedusing a liposomecentrifugation assay (Fig-
ure 4E). Taken together the results suggest that PTRF is a PS-
binding protein, which is recruited to caveolae in a cholesterol-
dependent manner and is an abundant component of caveolae.
PTRF Is Required for Caveola Formation in PC3 Cells
In view of the strict association of PTRF with caveolae, we tested
the hypothesis that PTRF aids caveola formation. Screening
a panel of cell lines revealed that protein levels of PTRF and
Cav1 closely parallel each other in most cell lines (data not
shown), with the exception of the prostate cancer cell line PC3,
which expressed abundant Cav1 but no detectable PTRF (Fig-
ure 4F). By IF, caveolin showed a diffuse staining in PC3 cells
(Figure 4G, cell on right), similar toC. elegans caveolin (Figure 3F),
which targets to the plasmamembrane but does not form caveo-
lae. In agreement with this, electron microscopic analysis of
ruthenium red surface-labeled cells showed extremely low levels
of morphologically recognizable caveolae (Figure 4H, occupying
< 0.2% of the plasma membrane surface as estimated by sterol-
ogy). Transfection of PTRF caused a dramatic change in Cav1
distribution by IF, with large puncta now visible in the transfected
cells (Figure 4G, cell on left). The transfected cells were pro-
cessed for electron microscopy (Figure 4H), and caveolae den-
sity in the transfected cell population was quantitated in a blind
fashion in comparison to control cells. Although the transfection
efficiency was less than 50%, the caveolae density dramatically
increased upon PTRF transfection with a 6.5-fold increase as
measured over the entire population (0.26 ± 0.13 caveolae per118 Cell 132, 113–124, January 11, 2008 ª2008 Elsevier Inc.field to 1.70 ± 0.94). Caveolae were evident as single structures
on the plasma membrane and in the characteristic surface-con-
nected ‘‘caves’’ or rosette structures described in many cell
types (Figure 4H). We conclude that PTRF is limiting for caveola
formation in this prostate cancer cell line.
Downregulation of PTRF Causes Loss
of Surface Caveolae
To further test the role of PTRF in caveolae formation, NIH 3T3
fibroblast cell lines with reduced PTRF levels were generated
by stable expression of shRNA (shPTRF) and compared to con-
trol lines generated in parallel with either a scrambled shRNA
vector or shRNA directed against Cav3 (shCON, note that
Cav3 is not expressed in NIH 3T3 fibroblasts). A reduction of
PTRF expression by 80%–95% caused a 10%–50% reduction
of Cav1 protein levels in different cell lines (an example is shown
in Figure 5A); however, the majority of Cav1 still localized to the
DRM fraction (Figure 5A). By IF, endogenous Cav1 showed a dif-
fuse surface distribution in shPTRF cells (Figure 5B), in contrast
to the characteristic linear and/or punctate distribution in paren-
tal NIH 3T3 fibroblasts (Figure 2B) or shCON cells (Figure 5B).
Importantly, we were able to restore the characteristic Cav1
staining pattern in shPTRF cells by re-expressing GFP-PTRF to
high levels to partially overcome the shRNA inhibition (Figure 5C).
To examine the effect of PTRF knockdown on caveolae, we
used ruthenium red to label the cell surface of shCON and
shPTRF cells. Control cells showed abundant 60–80 nm invagi-
nations of the cell surface, characteristic of caveolae (Figure 5D).
In contrast, caveolae were rare in shPTRF cells (Figure 5E). This
was quantitated in a blind fashion using two independent
methods and compared to the level of caveolae observed in
Cav1 knockdown cells generated using shRNA in NIH 3T3 cells
(Figure S5). The percentage of the cell surface occupied by cav-
eolae decreased from 10.9% ± 1.11% (n = 76 fields) in shCON
cells to 3.45% ± 0.43% (n = 65 fields) in shPTRF cells and
2.60% ± 0.64% in shCav1 cells (n = 54 fields), as measured by
standard stereological methods on random sections. Similar re-
sults were obtained by independent quantitation of caveolae
numbers per field in random areas of the cell surface. This corre-
sponds to a decrease of caveolae density of 68% upon PTRF
downregulation, as compared to 76% upon Cav1 knockdown
using similar methods and quantitated in parallel. There was no
evidence of abnormal caveolae formation in either case.
To investigate the distribution of Cav1 in shPTRF cells we per-
formed quantitative immuno-EM on frozen sections. In control
cells (shCON) themajority of Cav1 labeling (81.7% ± 4.6%of sur-
face labeling) was associated with 65 nm vesicles close to, or
clearly connected to, the plasma membrane (Figures 6A and
6B). In contrast, in shPTRF cells the bulk of plasma membrane
labeling was associated with noncaveolar plasma membrane
(79.1% ± 5.3%, Figures 6C–6E). The remaining 21% of surface
gold associatedwith caveolaemay reflect the incomplete knock-
down of PTRF. Total labeling for Cav1 (gold particles per random
field) was decreased approximately 25% in shPTRF cells, al-
though it is important to note thatwecannot assumesimilar label-
ing efficiency for Cav1 in caveolae and flat plasmamembrane. To
our surprise, in shPTRF cells, a significant, although low, fraction
of Cav1 was observed in clathrin-coated pits (for example, see
inset Figure S7A). Although less than 1% of total Cav1 labeling,
the significance of this association was indicated by the total ab-
sence of Cav1 labeling in clathrin-coated pits of shCON cells
labeled in parallel. Consistent with association of Cav1 with the
endocytic pathway upon PTRF downregulation, Cav1 labeling
was observed in endocytic structures, including multivesicular
putative late endosomes in shPTRF cells but not in shCON cells
(Figures S7A and S7B). Together with the observed decrease in
Cav1 levels, this raised the possibility that PTRF knockdown
could allow Cav1 to be internalized and degraded. Consistent
with this, cycloheximide chase experiments showed significant
degradation of Cav1within 6–8 hr in shPTRF cells but not shCON
cells (Figure 6F). This downregulation of Cav1was completely in-
hibitedby treatmentwith lysosomal inhibitors (results not shown).
Figure 5. PTRF Knockdown Reduces
Caveolae Density in NIH 3T3 Cells
NIH 3T3 fibroblasts were transfected with shRNA
to PTRF (shPTRF) or control shRNA (shCON). Sta-
ble cell lines were generated by selection in G418.
(A) shPTRF cells show reduction of PTRF expres-
sion without affecting Cav1 association with
DRMs on sucrose gradient.
(B) Immunofluorescence labeling of methanol-
fixed shCON and shPTRF cells shows punctuate
Cav1 labeling in shCON cells and diffuse labeling
in shPTRF cells. Note that PTRF antibody labeling
is weak under these conditions, which were opti-
mized to show the differential Cav1 labeling in
the two cell types. Bars, 1 mm.
(C) shPTRF NIH 3T3 fibroblasts were transfected
with PTRF-GFP and then labeled for Cav1. In
transfected cells Cav1 shows the characteristic
punctate staining seen in WT MEF, NIH 3T3, and
shCON cells, whereas untransfected cells (aster-
isks) show diffuse labeling for Cav1. Bars, 1 mm.
(D–F) To quantitate surface caveolae, shCON cells
(D) or shPTRF cells (E) were surface labeled by fix-
ation in the presence of ruthenium red. Abundant
caveolae, surface pits of approximately 65 nm di-
ameter, are apparent close to the surface of
shCON cells (arrowheads) but rarely in shPTRF
cells. Caveolae density (± SEM) was quantitated
(F) from three independent experiments as de-
scribed in Experimental Procedures. *p < 0.005
Bars, 200 nm.
The low level of labeling of the Golgi com-
plex, was similar in control and shPTRF
cells (Figures S7C and S7D), consistent
with the hypothesis that the principal
role for PTRF is to stabilize caveolin at
the plasma membrane rather than facili-
tate Golgi exit.
Caveolin in caveolae are reported to be
relatively immobile but can be mobilized
upon cholesterol depletion (Thomsen
et al., 2002). To examine if release of cav-
eolin by PTRF knockdown has a similar
effect, we performed FRAP (fluorescence recovery after photo-
bleaching) analysis on yellow fluorescent protein (YFP)-tagged
Cav1 transfected in shCON versus shPTRF cells (Figure 6G).
Consistent with previous reports (Thomsen et al., 2002), Cav1-
YFPmobility was extremely low in control cells, with an immobile
fraction of 0.778 (Figure 6B). The immobile fraction of Cav1-YFP
in shPTRF cells was significantly decreased to 0.369 (Figure 6B),
reminiscent of that seen in cholesterol-depleted cells (Thomsen
et al., 2002). In contrast, the half-life of fluorescence recovery
was not significantly different in the two cell lines. The mobile
fraction in each cell type (22% and 63% for shCON and shPTRF,
respectively) are not significantly different (t2 = 1.45, p = 0.228) to
the percentage of noncaveolar Cav1 observed in the immuno-
EM analysis (18% and 79%, respectively).Cell 132, 113–124, January 11, 2008 ª2008 Elsevier Inc. 119
Taken together, these results suggest that PTRF is required to
stabilize caveolin in caveolae at the plasma membrane. Loss of
PTRF causes caveolin to diffuse freely in the plasma membrane
and to become internalized (presumably as a passive bulk flow
marker) into the endolysosomal system where degradation oc-
curs. These data agree with a model in which sequestration of
caveolin into caveolae, promoted by PTRF, causes stable con-
finement of caveolin, thus protecting it from degradation.
PTRF Is Required for Caveola Formation
and Notochord Structure in Zebrafish
In order to determine whether PTRF was also required for cav-
eola formation in vivo we made use of the zebrafish, Danio rerio.
We have recently demonstrated the high expression of Cav1
Figure 6. PTRF Knockdown Causes Redistribution
of Cav1 to Noncaveolar Membrane, Increases the
Cav1 Degradation and Lateral Mobility at the
Plasma Membrane
(A–E) Localization of Cav1 was examined in shCON (A and
B) and shPTRF (C–E) cells by quantitative immunoelectron
microscopy on frozen sections. In control cells, 81.7% ±
4.6% of surface caveolin was associated with 65 nm ves-
icles close to, or clearly connected to, the plasma mem-
brane (arrowheads, A and B). In contrast, 79.1% ± 5.3%
of surface caveolin labeling was associated with nonca-
veolar membrane in shPTRF cells. Bars, 200 nm. pm,
plasma membrane.
(F) PTRF knockdown accelerates the degradation of Cav1.
shPTRF and shCON cells were treated with 10 mM cyclo-
heximide for the indicated times and the level of Cav1
protein assessed by immunoblotting whole cell lysates.
Tubulin was used as a loading control. Graph represents
data (± SEM) from two independent experiments.
(G) PTRF knockdown results in a highly significant in-
crease (p < 0.001) in the mobile fraction of Cav1. Control
and shPTRF fibroblasts were transiently transfected with
YFP-Cav1. A 36 mm2 area of the cell (boxed in the second
image) was bleached to background levels, and images
were then captured at 14 s intervals. The mean of normal-
ized data (± SEM) from ten independent FRAP experi-
ments per cell type are plotted and the td and Rf derived
from a one-phase exponential association fit to the data.
The half life (td) for shCON was not significantly different
from shPTRF (74 s and 60 s, respectively).
and caveolae in the notochord of the zebrafish
embryo (Nixon et al., 2007). Formation of caveo-
lae in the notochord occurs early in develop-
ment, and notochord caveolae are highly
abundant and easily quantified. Since gene
expression can be readily ablated using mor-
pholino (MO) technology at this stage of devel-
opment, this offers a powerful in vivo system
to study caveolae formation. The cDNA for the
putative zebrafish ptrf was cloned by PCR
based on a predicted protein from Ensembl,
transcript number GENSCAN00000026855.
The putative zebrafish Ptrf protein is 50% iden-
tical and 62% similar to human PTRF.
The zebrafish ptrf homolog was clearly detected within the no-
tochord at 18–31 hr postfertilization by in situ hybridization (Fig-
ure 7), overlapping with the expression of cav1 (Fang et al., 2006;
Nixon et al., 2007). In addition, at later stages of development,
expression of ptrf could be detected in blood vessels, branchial
arches, and otic vesicles (Figure 7C). ptrf expression was first
detected in the notochord of 18 hr embryos (Figure 7F,G), with
labeling absent in 16 hr embryos (Figures 7D and 7E). This was
of high interest as cav1 expression was detected as early as
12 hr (Figure 7I) (Fang et al., 2006; Nixon et al., 2007). The differ-
ential expression of ptrf and cav1 transcripts in early zebrafish
embryos was confirmed by RT-PCR (Figure 7H), and we further
confirmed the expression of Cav1 protein by immunohistochem-
istry in 16 hr embryos (Figure 7J). Notochord ultrastructure from120 Cell 132, 113–124, January 11, 2008 ª2008 Elsevier Inc.
Figure 7. PTRF Is Required for Caveola Formation in
Zebrafish Notochord Cells
(A–G) Expression pattern of ptrf during zebrafish development
was analyzed by whole-mount mRNA in situ hybridization. Ante-
rior is to the left and dorsal to the top. ptrf expression was
detected in the notochord (n) in 24 hr embryos (A) and 31 hr em-
bryos (B). In 72 hr embryos (C), expression was detected in dorsal
blood vessels (dbv), in the otic vesicle (ov), and in the branchial
arches (ba). ptrf mRNA expression was first detected in 18 hr
embryos (F and G), and it was not detected in 16 hr embryos
(D and E).
(H) RT-PCR comparing the temporal mRNA expression pattern of
ptrf and cav1 during early embryo development. ptrf mRNA ex-
pression arose at 18 hr and was maintained throughout the devel-
opment until 72 hr. cav1 mRNA expression was detected earlier
than ptrf and was detected in the notochord as early as 12 hr
by in situ hybridization (I). Expression of Cav1 protein was
observed in the notochord by immunohistochemistry of 16 hr
embryos (J). Arrowheads in (A)–(J) indicate the notochord.
(K and L) Ptrf knockdown embryos were generated by morpho-
lino (MO) injection (6 ng/embryo). At 48 hr, 79% of control MO in-
jected embryos appeared normal (K), whereas 44% of embryos
injected with PTRF MO were curved under and/or presented
heart edema (L).
(M–Q) Ultrastructural analysis and immunogold labeling of the no-
tochord of 48 hr embryos injected with control MO (M and O) or
PTRF MO (N, P, and Q). In the regions of cell-cell contact, the
plasma membranes (PM) of neighboring cells are closely ap-
posed. The plasma membrane in these regions is covered in cav-
eolae (some of which are indicated by arrowheads) in the control
MO-injected embryos (M). Caveolin immunogold labeling (arrow-
heads) is associated with the invaginated caveolae as seen in
frozen sections labeled in parallel (O). The density of caveolae
is greatly reduced in PTRF MO-injected embryos (N), and the
plasma membranes of neighboring cells are less closely ap-
posed. Caveolin labeling is associated predominantly with flat
plasma membrane rather than invaginated caveolae in the
PTRF MO-injected embryos (P and Q). pm, plasma membrane.
Scale bars (A, B, C, D, F, I, J, K, and L), 250 mm, (E and G) 80 mm,
and (M–Q) 200 nm.16 hr and 24 hr embryos was examined by electron microscopy
(Figure S8). In agreement with our previous data, morphological
caveolae were not detectable at 16 hr, but was highly abundant
at 24 hr, again supporting a role for PTRF in caveolae formation.
To examine whether Ptrf is required for caveola formation in
the zebrafish, we performed Ptrf knockdown in zebrafish em-
bryos. Injection of PTRF-MO produced a curved phenotype in
42% of the injected embryos (Figures 7K and 7L), identical to
the curved phenotype observed in Cav1-MO zebrafish embryos
(Nixon et al., 2007). Similar results were obtained using a splic-
ing-blocking MO. Quantitation of caveolae density in the noto-
chord of PTRF-MOand control-MO zebrafish showed a dramatic
reduction in caveolae upon Ptrf downregulation (Figures 7M and
7N). Caveolae density correlated with the severity of phenotype
(mild 43.7% ± 5.5% of caveolae in the notochord of control MO-
injected embryos; severe 23.6% ± 3.6% of control). The level ofcaveolae reduction is comparable to that reported for Caveolin-
MO (Fang et al., 2006; Nixon et al., 2007).We examined the local-
ization of Cav1 in PTRF-MO embryos by immuno-EM (Figures
7O–7Q). In control-MO notochord, the plasma membranes be-
tween two adjacent cells are tightly opposed and contain numer-
ous Cav1-decorated caveolae (Figure 7O). In contrast, gaps can
be observed between neighboring notochord cells in PTRF
MO-injected embryos (Figure 7N), and Cav1 labeling is mainly
associated with flat membrane (Figures 7P and 7Q). These re-
sults show that PTRF is required for caveola formation in vivo
and that this role is conserved in evolution.
DISCUSSION
In this studywe have shown that PTRF, a protein initially identified
as a transcript release factor, is required for caveola formation inCell 132, 113–124, January 11, 2008 ª2008 Elsevier Inc. 121
mammals and the zebrafish. We suggest that the name PTRF-
Cavin would be more appropriate for this protein. PTRF-Cavin
shows unique properties; it associates with mature caveolae at
the plasma membrane but does not associate with noncaveolar
caveolin (in the Golgi complex or with mutant forms of caveolin).
This interaction is conserved in evolution; mammalian PTRF-
Cavin even associates with caveolae generated by expression
of invertebratecaveolins.PTRF-Cavin,unlikecaveolin, isasoluble
cytosolicprotein recruited to themembrane togenerate caveolae.
Togetherwith theabundanceofPTRF-Cavin incaveolae, thissug-
gests that PTRF-Cavin operates as a coat protein for caveolae.
The current model of caveolae biogenesis suggests that cav-
eolae form at the Golgi complex in a process involving caveolin
oligomerization and cholesterol binding and traffic as a unit
that fuses directly with the plasma membrane (Tagawa et al.,
2005). Once at the plasmamembrane, caveolae are relatively im-
mobile but can be endocytosed, to be recycled or fuse with the
endosome or the caveosome (Kirkham et al., 2005; Pelkmans
et al., 2002; Thomsen et al., 2002). A unique feature of the caveo-
lar domain, as illustrated in these studies, was the maintenance
of the stable caveolar unit despite multiple rounds of endocytic
transport. This is quite different to the assembly and disassembly
of coat components of classical coated structures such as cla-
thrin-coated vesicles. In agreement with this model, we did not
detect a change in PTRF-Cavin/caveolin interaction upon stimu-
lation of caveolae endocytosis (data not shown). Individual cav-
eolae were estimated to each contain 144 molecules of caveolin
(Pelkmans and Zerial, 2005). PTRF-Cavin is also clearly an abun-
dant component of caveolae as shown here and suggested in
previous studies based on immunogold labeling density (Vold-
stedlund et al., 2001). High ectopic expression of caveolin results
in association of caveolin with noncaveolar domains, where it
shows higher lateral mobility (Pelkmans and Zerial, 2005).
PTRF-Cavinmay be one component that becomes limiting under
these conditions, since downregulation of PTRF-Cavin causes
a loss of caveolae but caveolin remains at the plasmamembrane
and associated with DRMs. The possibility that the caveolar unit
can be disassembled, through dissociation of PTRF, to release
caveolin and other sequestered components in the bulk mem-
brane can now be examined.
How does PTRF recognize and stabilize caveolae? While we
can show close association of caveolin and PTRF-Cavin, our in-
ability to consistently detect their stable association using immu-
noprecipitation techniques raises the possibility of an indirect
role of caveolin and the potential involvement of membrane
lipids. We have now shown binding of recombinant PTRF-Cavin
with PS in vitro (Figures 4D and 4E) and a requirement for choles-
terol for PTRF-Cavin/caveolin interaction (Figure 4C). As the cav-
eolin scaffolding domain has been proposed to oligomerize
in vitro to form lateral membrane domains containing PS and
cholesterol (Wanaski et al., 2003), an intriguing possibility is
that PTRF-Cavin binds caveolin-generated PS-cholesterol do-
mains, thus stabilizing the membrane curvature of caveolae.
This is consistent with the fact that even an invertebrate caveolin,
with limited sequence conservation, when expressed in mam-
malian cells, can recruit PTRF-Cavin.Our results suggest amodel
where caveolae biogenesis would primarily involve caveolin-
driven domain formation, but with PTRF-Cavin providing critical122 Cell 132, 113–124, January 11, 2008 ª2008 Elsevier Inc.stability for the nascent caveolar structures. Whether the mech-
anisms involved show any similarities to the generation of curva-
ture in other systems, such as those driven by BAR domain
proteins (Dawson et al., 2006), will await further detailed investi-
gation of the cooperation between caveolin and PTRF-Cavin,
and a detailed understanding of the membrane lipid-protein in-
teractions involved.
Conclusions
In this study, we have defined PTRF-Cavin as an essential com-
ponent of caveolae.Wepropose a newmodel of caveolae forma-
tion and function in which PTRF-Cavin is recruited to membrane
domains containing PS, cholesterol, and oligomerized caveolins.
Binding of PTRF-Cavin to these domains stabilizes the mem-
brane curvature to produce the classic flask shape of caveolae.
Loss of PTRF-Cavin releases caveolar components, including
caveolins into the plasma membrane. The level of noncaveolar
caveolins are tightly regulated via endolysosomal degradation.
PTRF-Cavin is therefore a potential caveolar coat protein that
regulates caveola structure and function.
EXPERIMENTAL PROCEDURES
Electron Microscopy and Quantitation
Labeling of the cell surface by ruthenium red fixation was performed as previ-
ously described (Parton et al., 2002). The percentage area of the cell surface
occupied by caveolae was estimated by intersection counting as in previous
studies (Parton, 1994), except that counting was performed on captured
images (Jeol 1011 TEM equipped withMorada cooled CCD camera and Olym-
pus Soft Imaging Solutions Gmbh, Germany with AnalySIS software) at a mag-
nification of 15,000–20,0003. Images were captured at random from different
areas of the monolayer and overlayed with appropriate double-lattice grids to
measure intersections with the plasma membrane (253 grid) and with caveo-
lae (13 grid) defined as 60–100 nm uncoated invaginations of the ruthenium
red-labeled plasma membrane. Two independent fields from each of at least
two independent experiments were quantitated for each condition, and similar
results were obtained in double-blind experiments inwhich codeswere broken
after quantitation.
FRET imaging
FRET was measured as sensitized acceptor emission using the three-cube
method as previously described (Erickson et al., 2001). Images in donor (ex
405 nm, em 470–500 nm), acceptor (ex 514 nm, em 530–600 nm) and FRET
(ex 405 nm, em 530–600 nm) channels were acquired on a Zeiss LSM 510
Meta using a 633 or 1003 oil immersion objective, with numerical apertures
of 1.4. Living cells were imaged in PBS/1 mM CaCl2.
FLIM
FLIM experiments were carried out using a lifetime fluorescence imaging
attachment (Lambert Instruments, Leutingwolde, The Netherlands) on an in-
verted microscope (Olympus IX71). BHK cells transiently expressing mGFP-
PTRF (donor), alone or withmRFP-Cav3 (acceptor) (using a 1:3 ratio of plasmid
DNA) were excited using a sinusoidally modulated 3W 470 nm LED at 80 MHz
under epi-illumination. Fluorescein was used as a lifetime reference standard.
Cells were imaged with a 603 NA 1.45 oil objective using an appropriate GFP
filter set. The phase and modulation were determined from a set of 12 phase
settings using the manufacturer’s software. Resolution of two lifetimes in the
frequency domain, pixel by pixel, was performed using the polar plot method
(Clayton et al., 2004) again as implemented in the manufacturer’s software.
Additional Experimental Procedures are available as Supplemental Data.
Supplemental Data
Supplemental Data include seven figures, Supplemental Experimental Proce-
dures, and Supplemental References and can be found with this article online
at http://www.cell.com/cgi/content/full/132/1/113/DC1/.
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